Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial assessing the efficacy and safety of once-weekly semaglutide added to SGLT-2 inhibitors versus placebo in adults with type 2 d…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study [NA]
Clinical trial update for ESR-15-11293 (Saxa/Dapa) evaluating safety and efficacy in type 2 diabetes; trial completed with results posted in…
-
FDA approval · 2019-08-13FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2019-08-12FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA grants approval of a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2019-08-12FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin HCl) from Merck Sharp & Dohme LLC, updating the labeling …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-12FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
-
FDA approval · 2019-08-12FDA Tentative Approval: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA issued tentative approval for a generic fixed-dose combination of dapagliflozin and metformin hydrochloride, manufactured by Prasco Labo…
-
FDA approval · 2019-08-08FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for XULTOPHY 100/3.6, a fixed-ratio combination of insulin degludec and liraglutide, from Novo N…
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine [Phase 3]
A Phase 3 trial comparing SAR341402 to NovoLog/NovoRapid in adults with diabetes using insulin glargine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: EMPRA (EMPagliflozin and RAs in Kidney Disease) [Phase 2]
Phase 2 trial update of EMPRA studying empagliflozin in kidney disease; completed study in Type 2 diabetes with diabetic kidney disease and …
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: A Study of LY2922083 in Healthy Participants and Participants With Diabetes [Phase 1]
Phase 1 study of LY2922083 in healthy participants and participants with type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia [Phase 2]
A Phase 2 trial comparing naltrexone-bupropion to placebo-bupropion for weight loss in individuals with schizophrenia has been terminated; r…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake [NA]
A completed clinical trial evaluating the cooperation of insulin and GLP-1 on myocardial glucose uptake in individuals with type 2 diabetes,…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update evaluating how dapagliflozin affects HDL particle subtypes and reverse cholesterol transport in patients with …
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Assessment of Mealtime Bolus Insulin Behavior
Clinical trial update reporting completed status and results for a study assessing mealtime bolus insulin behavior in diabetes.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients [Phase 1, Phase 2]
Clinical trial update evaluating measurement of eye blood flow and renal function in healthy and Type 2 Diabetes Mellitus patients across Ph…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes [Phase 1, Phase 2]
Clinical trial updates on vitamin D and calcium homeostasis for prevention of Type 2 diabetes (Phase 1/Phase 2) with completed status and re…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes [Phase 3]
Phase 3 trial comparing empagliflozin plus linagliptin versus metformin plus insulin glargine in type 2 diabetes focusing on renal and vascu…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial comparing the efficacy and safety of insulin degludec/liraglutide combination versus insulin degludec alone and liraglutide al…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED) [NA]
Clinical trial update for a study on diabetes (Type 2) that has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) [Phase 3]
Phase 3 trial evaluating combined liraglutide and metformin therapy in women with prior gestational diabetes mellitus; study completed with …
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial update on metformin SR tablets (DuLeNing) and Glucophage in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia [Phase 4]
Phase 4 trial comparing rosuvastatin/ezetimibe versus rosuvastatin in Korean patients with type 2 diabetes mellitus and hypercholesterolemia…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects [Phase 4]
Phase 4 trial updating CYP450 activity in diabetic versus non-diabetic subjects.
-
FDA approval · 2019-07-22FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Metformin Hydrochloride from Sun Pharmaceutical Industries, Inc., validating a generic metfo…